Technology Overview

Physalis angulata Linn is a ground cherry native to Indonesia. It is traditionally used as a medicinal plant. The institute has developed processes and formulations for extracting the juice from the fruit and buds of Physalis angulata Linn. Post extraction, the juice will be processed into a ready-to-drink juice that is rich in antioxidant and flavonoid contents. This product has been evaluated by in vitro and in vivo assays for antidiabetic beverage as well as its shelf-life. This drink can be consumed by diabetics or anyone because it has a refreshing taste. The institute is looking for industry partner to license the process and formulation to manufacture and commercialise the products developed.

Technology Features, Specifications and Advantages

The technology maintains the stability of active compounds in the product, extending the shelf-life of the product.

Potential Applications

The developed Physalis angulata Linn juice is suitable for diabetic patients or persons who are at high risk of being diabetic. This product can also be consumed by anyone to maintain good health. Due to the high content of polyphenols and other antioxidant compounds found in the juice, it may be able to reduce oxidative stress related disease.

Customer Benefit

The first innovative aspect is this product could reduce a blood sugar level in diabetic mice and may serve as an alternative to medicine. Because produced from natural product, this product will have negative impact for human health. Technology adopters will benefit from a high profit bargain due to the low-cost production of this juice and the ability to price it at a higher selling point for its functional properties.